

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 8.32990959 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 8.22973123 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.57995227 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.57995227 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.28355333 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.28355333 |
| 7 | * aromatic amino acid family catabolic process (GO:0009074) | 7.05491708 |
| 8 | glyoxylate metabolic process (GO:0046487) | 6.85043280 |
| 9 | * indole-containing compound catabolic process (GO:0042436) | 6.61581724 |
| 10 | * indolalkylamine catabolic process (GO:0046218) | 6.61581724 |
| 11 | * tryptophan catabolic process (GO:0006569) | 6.61581724 |
| 12 | urate metabolic process (GO:0046415) | 6.39822724 |
| 13 | drug transmembrane transport (GO:0006855) | 6.33610480 |
| 14 | fibrinolysis (GO:0042730) | 6.22660722 |
| 15 | * tryptophan metabolic process (GO:0006568) | 6.19582007 |
| 16 | oxidative demethylation (GO:0070989) | 6.18934385 |
| 17 | lysine metabolic process (GO:0006553) | 6.14086668 |
| 18 | lysine catabolic process (GO:0006554) | 6.14086668 |
| 19 | cysteine metabolic process (GO:0006534) | 6.13796660 |
| 20 | kynurenine metabolic process (GO:0070189) | 6.00998240 |
| 21 | blood coagulation, intrinsic pathway (GO:0007597) | 5.80917927 |
| 22 | homocysteine metabolic process (GO:0050667) | 5.70610140 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 5.67722234 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.40489174 |
| 25 | bile acid biosynthetic process (GO:0006699) | 5.39234026 |
| 26 | drug transport (GO:0015893) | 5.29082702 |
| 27 | drug catabolic process (GO:0042737) | 5.21753613 |
| 28 | phenylpropanoid metabolic process (GO:0009698) | 5.14463487 |
| 29 | urea metabolic process (GO:0019627) | 5.14000239 |
| 30 | urea cycle (GO:0000050) | 5.14000239 |
| 31 | exogenous drug catabolic process (GO:0042738) | 5.07162332 |
| 32 | * aromatic amino acid family metabolic process (GO:0009072) | 5.06508528 |
| 33 | S-adenosylmethionine metabolic process (GO:0046500) | 5.01021075 |
| 34 | sulfur amino acid catabolic process (GO:0000098) | 5.00560297 |
| 35 | amino-acid betaine metabolic process (GO:0006577) | 4.98115570 |
| 36 | regulation of plasminogen activation (GO:0010755) | 4.94947883 |
| 37 | ethanol metabolic process (GO:0006067) | 4.85453053 |
| 38 | * alpha-amino acid catabolic process (GO:1901606) | 4.81857539 |
| 39 | serine family amino acid metabolic process (GO:0009069) | 4.80745282 |
| 40 | nitrogen cycle metabolic process (GO:0071941) | 4.76851815 |
| 41 | protein activation cascade (GO:0072376) | 4.74095158 |
| 42 | negative regulation of blood coagulation (GO:0030195) | 4.67027909 |
| 43 | negative regulation of hemostasis (GO:1900047) | 4.67027909 |
| 44 | cellular glucuronidation (GO:0052695) | 4.65954487 |
| 45 | * cellular biogenic amine catabolic process (GO:0042402) | 4.65082921 |
| 46 | * amine catabolic process (GO:0009310) | 4.65082921 |
| 47 | * indolalkylamine metabolic process (GO:0006586) | 4.62840213 |
| 48 | cellular modified amino acid catabolic process (GO:0042219) | 4.58294847 |
| 49 | tyrosine metabolic process (GO:0006570) | 4.52181958 |
| 50 | benzene-containing compound metabolic process (GO:0042537) | 4.51777720 |
| 51 | * cellular amino acid catabolic process (GO:0009063) | 4.51183607 |
| 52 | alkaloid metabolic process (GO:0009820) | 4.44850910 |
| 53 | complement activation, alternative pathway (GO:0006957) | 4.43711339 |
| 54 | glucuronate metabolic process (GO:0019585) | 4.42941238 |
| 55 | uronic acid metabolic process (GO:0006063) | 4.42941238 |
| 56 | bile acid metabolic process (GO:0008206) | 4.41238255 |
| 57 | serine family amino acid biosynthetic process (GO:0009070) | 4.39963738 |
| 58 | complement activation (GO:0006956) | 4.38443196 |
| 59 | phospholipid efflux (GO:0033700) | 4.34781976 |
| 60 | short-chain fatty acid metabolic process (GO:0046459) | 4.34567297 |
| 61 | regulation of protein activation cascade (GO:2000257) | 4.30673503 |
| 62 | complement activation, classical pathway (GO:0006958) | 4.30625447 |
| 63 | acute-phase response (GO:0006953) | 4.27036790 |
| 64 | aldehyde catabolic process (GO:0046185) | 4.26050752 |
| 65 | regulation of humoral immune response (GO:0002920) | 4.25937591 |
| 66 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.25805474 |
| 67 | negative regulation of protein activation cascade (GO:2000258) | 4.25362360 |
| 68 | negative regulation of coagulation (GO:0050819) | 4.23709087 |
| 69 | glutamate metabolic process (GO:0006536) | 4.21264661 |
| 70 | negative regulation of wound healing (GO:0061045) | 4.20632578 |
| 71 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.20610286 |
| 72 | protein carboxylation (GO:0018214) | 4.20610286 |
| 73 | organic cation transport (GO:0015695) | 4.18872221 |
| 74 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.18647141 |
| 75 | cholesterol efflux (GO:0033344) | 4.17114285 |
| 76 | aspartate family amino acid catabolic process (GO:0009068) | 4.14945601 |
| 77 | response to mercury ion (GO:0046689) | 4.13595177 |
| 78 | coenzyme catabolic process (GO:0009109) | 4.13531746 |
| 79 | cellular ketone body metabolic process (GO:0046950) | 4.10796688 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 4.09516748 |
| 81 | protein-lipid complex remodeling (GO:0034368) | 4.09516748 |
| 82 | macromolecular complex remodeling (GO:0034367) | 4.09516748 |
| 83 | glycine metabolic process (GO:0006544) | 4.09448502 |
| 84 | negative regulation of fibrinolysis (GO:0051918) | 4.08775779 |
| 85 | regulation of complement activation (GO:0030449) | 4.05666373 |
| 86 | NAD biosynthetic process (GO:0009435) | 4.04120905 |
| 87 | regulation of fibrinolysis (GO:0051917) | 4.01277351 |
| 88 | opsonization (GO:0008228) | 3.97207554 |
| 89 | alpha-linolenic acid metabolic process (GO:0036109) | 3.95980877 |
| 90 | cytolysis (GO:0019835) | 3.94809550 |
| 91 | * organic acid catabolic process (GO:0016054) | 3.93570278 |
| 92 | * carboxylic acid catabolic process (GO:0046395) | 3.93570278 |
| 93 | high-density lipoprotein particle remodeling (GO:0034375) | 3.90670740 |
| 94 | acetyl-CoA metabolic process (GO:0006084) | 3.88070849 |
| 95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.87223132 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.87223132 |
| 97 | positive regulation of blood coagulation (GO:0030194) | 3.85855367 |
| 98 | positive regulation of hemostasis (GO:1900048) | 3.85855367 |
| 99 | intestinal cholesterol absorption (GO:0030299) | 3.84739185 |
| 100 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.83590082 |
| 101 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.83590082 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.82372631 |
| 103 | reverse cholesterol transport (GO:0043691) | 3.81706572 |
| 104 | arginine metabolic process (GO:0006525) | 3.81572480 |
| 105 | 2-oxoglutarate metabolic process (GO:0006103) | 3.81160285 |
| 106 | branched-chain amino acid metabolic process (GO:0009081) | 3.79748127 |
| 107 | heme transport (GO:0015886) | 3.79136949 |
| 108 | valine metabolic process (GO:0006573) | 3.78469377 |
| 109 | daunorubicin metabolic process (GO:0044597) | 3.78101373 |
| 110 | polyketide metabolic process (GO:0030638) | 3.78101373 |
| 111 | doxorubicin metabolic process (GO:0044598) | 3.78101373 |
| 112 | carnitine metabolic process (GO:0009437) | 3.74622648 |
| 113 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.73648576 |
| 114 | hormone catabolic process (GO:0042447) | 3.72357624 |
| 115 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.71964405 |
| 116 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.71898455 |
| 117 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.71898455 |
| 118 | flavonoid metabolic process (GO:0009812) | 3.71813902 |
| 119 | bile acid and bile salt transport (GO:0015721) | 3.71395170 |
| 120 | acylglycerol homeostasis (GO:0055090) | 3.70650720 |
| 121 | triglyceride homeostasis (GO:0070328) | 3.70650720 |
| 122 | fatty acid beta-oxidation (GO:0006635) | 3.68390071 |
| 123 | imidazole-containing compound metabolic process (GO:0052803) | 3.67689150 |
| 124 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.67430827 |
| 125 | fatty acid oxidation (GO:0019395) | 3.67053814 |
| 126 | branched-chain amino acid catabolic process (GO:0009083) | 3.66873829 |
| 127 | phosphate ion transport (GO:0006817) | 3.66710553 |
| 128 | response to nitrosative stress (GO:0051409) | 3.66210196 |
| 129 | xenobiotic metabolic process (GO:0006805) | 3.65391070 |
| 130 | * indole-containing compound metabolic process (GO:0042430) | 3.64713958 |
| 131 | lipid oxidation (GO:0034440) | 3.60515888 |
| 132 | regulation of bile acid biosynthetic process (GO:0070857) | 3.60355075 |
| 133 | ethanol oxidation (GO:0006069) | 3.59128378 |
| 134 | positive regulation of coagulation (GO:0050820) | 3.58190995 |
| 135 | regulation of triglyceride catabolic process (GO:0010896) | 3.56812567 |
| 136 | amino acid salvage (GO:0043102) | 3.56496505 |
| 137 | L-methionine salvage (GO:0071267) | 3.56496505 |
| 138 | L-methionine biosynthetic process (GO:0071265) | 3.56496505 |
| 139 | steroid catabolic process (GO:0006706) | 3.55358832 |
| 140 | fructose metabolic process (GO:0006000) | 3.53264678 |
| 141 | ketone body metabolic process (GO:1902224) | 3.52356172 |
| 142 | monocarboxylic acid catabolic process (GO:0072329) | 3.51872717 |
| 143 | regulation of cholesterol esterification (GO:0010872) | 3.46406335 |
| 144 | cofactor catabolic process (GO:0051187) | 3.43371641 |
| 145 | drug metabolic process (GO:0017144) | 3.40686167 |
| 146 | proline metabolic process (GO:0006560) | 3.40229169 |
| 147 | negative regulation of cholesterol transport (GO:0032375) | 3.39349395 |
| 148 | negative regulation of sterol transport (GO:0032372) | 3.39349395 |
| 149 | fatty acid catabolic process (GO:0009062) | 3.38371900 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.69155228 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.07574655 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.51006401 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.83882354 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.81382861 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.77495198 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.04346394 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.81569686 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.60105495 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.01835197 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.78888272 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.30095212 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.17480205 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.12373385 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8741934 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.88334629 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.85156686 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78176397 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.71636723 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.57711334 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.56966595 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55675986 |
| 23 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.54832959 |
| 24 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.49063631 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42404484 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.41847562 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40900472 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33334267 |
| 29 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.29951739 |
| 30 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.27922245 |
| 31 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.23133068 |
| 32 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.21910347 |
| 33 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.20914121 |
| 34 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.20914121 |
| 35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18775028 |
| 36 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18013769 |
| 37 | NFYA_21822215_ChIP-Seq_K562_Human | 1.17669754 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.17499588 |
| 39 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16954958 |
| 40 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15538923 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11725369 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11511627 |
| 43 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10298520 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.08228455 |
| 45 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.05930284 |
| 46 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03698257 |
| 47 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.03588016 |
| 48 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.03306328 |
| 49 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.99224431 |
| 50 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97294098 |
| 51 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96500234 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96470616 |
| 53 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.95926630 |
| 54 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.95926151 |
| 55 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.95405672 |
| 56 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94813163 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94310991 |
| 58 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94037918 |
| 59 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93170529 |
| 60 | AR_20517297_ChIP-Seq_VCAP_Human | 0.91846886 |
| 61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90705183 |
| 62 | NFYB_21822215_ChIP-Seq_K562_Human | 0.90568010 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89606883 |
| 64 | TBL1_22424771_ChIP-Seq_293T_Human | 0.89223651 |
| 65 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.88573892 |
| 66 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.87955861 |
| 67 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87912255 |
| 68 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.87417465 |
| 69 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87220833 |
| 70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86746099 |
| 71 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86065856 |
| 72 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85267118 |
| 73 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.84776618 |
| 74 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.84633785 |
| 75 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.84561786 |
| 76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83796295 |
| 77 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83784762 |
| 78 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.83489338 |
| 79 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.82981593 |
| 80 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.82958441 |
| 81 | P300_19829295_ChIP-Seq_ESCs_Human | 0.82116621 |
| 82 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.81782462 |
| 83 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.81744050 |
| 84 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.81674410 |
| 85 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.81643404 |
| 86 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81518481 |
| 87 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.81009268 |
| 88 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80427540 |
| 89 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.80310963 |
| 90 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80195308 |
| 91 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80078386 |
| 92 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.79081650 |
| 93 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.78266107 |
| 94 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.78191379 |
| 95 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.77463361 |
| 96 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.76477382 |
| 97 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.76221482 |
| 98 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.76048147 |
| 99 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75858393 |
| 100 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.75858393 |
| 101 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.75713864 |
| 102 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.75568495 |
| 103 | ERA_21632823_ChIP-Seq_H3396_Human | 0.74662242 |
| 104 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.73682558 |
| 105 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.72944327 |
| 106 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.72529167 |
| 107 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.72041268 |
| 108 | NCOR_22424771_ChIP-Seq_293T_Human | 0.70998093 |
| 109 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.70776309 |
| 110 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.70776309 |
| 111 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.70667377 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69104858 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.68932756 |
| 114 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.68054753 |
| 115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67627365 |
| 116 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67627365 |
| 117 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67572310 |
| 118 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.67328371 |
| 119 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67322725 |
| 120 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.66666891 |
| 121 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.66446834 |
| 122 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.65344120 |
| 123 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.64165369 |
| 124 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.63153695 |
| 125 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.62037472 |
| 126 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61899021 |
| 127 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.61129583 |
| 128 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.60039320 |
| 129 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.59370956 |
| 130 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.59238980 |
| 131 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.58785053 |
| 132 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58727889 |
| 133 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.58429289 |
| 134 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.58124522 |
| 135 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.58098365 |
| 136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.57718061 |
| 137 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.57717347 |
| 138 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.57576821 |
| 139 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.57348772 |
| 140 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.57224208 |
| 141 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56793288 |
| 142 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.56589436 |
| 143 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.56235964 |
| 144 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.56199477 |
| 145 | CBP_21632823_ChIP-Seq_H3396_Human | 0.55962248 |
| 146 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.55075884 |
| 147 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.54970035 |
| 148 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.54970035 |
| 149 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.54677905 |
| 150 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.54071160 |
| 151 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53631181 |
| 152 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52747629 |
| 153 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.52531677 |
| 154 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.51356729 |
| 155 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.50781219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.28272448 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.60500204 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.67440390 |
| 4 | MP0005365_abnormal_bile_salt | 5.35640874 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.55590148 |
| 6 | MP0005332_abnormal_amino_acid | 3.81886717 |
| 7 | MP0003252_abnormal_bile_duct | 3.71970540 |
| 8 | MP0003195_calcinosis | 3.54971578 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.49824281 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 3.46617993 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 3.14047665 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.64161172 |
| 13 | MP0009643_abnormal_urine_homeostasis | 2.31273471 |
| 14 | MP0004043_abnormal_pH_regulation | 2.26622874 |
| 15 | MP0005083_abnormal_biliary_tract | 2.18420584 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.06481419 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.01123377 |
| 18 | MP0003186_abnormal_redox_activity | 1.94983321 |
| 19 | MP0005636_abnormal_mineral_homeostasis | 1.92551326 |
| 20 | MP0001764_abnormal_homeostasis | 1.89788050 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.84022958 |
| 22 | MP0009840_abnormal_foam_cell | 1.78218139 |
| 23 | MP0000609_abnormal_liver_physiology | 1.72476337 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.68147069 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.67009724 |
| 26 | MP0009697_abnormal_copulation | 1.54561377 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.53928351 |
| 28 | MP0005451_abnormal_body_composition | 1.46839918 |
| 29 | MP0005084_abnormal_gallbladder_morpholo | 1.45316153 |
| 30 | MP0001756_abnormal_urination | 1.42753506 |
| 31 | MP0002136_abnormal_kidney_physiology | 1.40373366 |
| 32 | MP0001765_abnormal_ion_homeostasis | 1.38387960 |
| 33 | MP0009764_decreased_sensitivity_to | 1.38189240 |
| 34 | MP0004147_increased_porphyrin_level | 1.37040073 |
| 35 | MP0003868_abnormal_feces_composition | 1.31560674 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.26037597 |
| 37 | MP0005670_abnormal_white_adipose | 1.16180087 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.05785133 |
| 39 | MP0008469_abnormal_protein_level | 1.03345530 |
| 40 | MP0000598_abnormal_liver_morphology | 1.02317128 |
| 41 | MP0005647_abnormal_sex_gland | 1.01970872 |
| 42 | MP0005408_hypopigmentation | 0.98892463 |
| 43 | MP0005187_abnormal_penis_morphology | 0.98112247 |
| 44 | MP0002928_abnormal_bile_duct | 0.96510304 |
| 45 | MP0009053_abnormal_anal_canal | 0.95533744 |
| 46 | MP0009642_abnormal_blood_homeostasis | 0.94816095 |
| 47 | MP0003879_abnormal_hair_cell | 0.90780760 |
| 48 | MP0003724_increased_susceptibility_to | 0.87996748 |
| 49 | MP0009763_increased_sensitivity_to | 0.87957290 |
| 50 | MP0005058_abnormal_lysosome_morphology | 0.87532063 |
| 51 | MP0005535_abnormal_body_temperature | 0.84817732 |
| 52 | MP0002282_abnormal_trachea_morphology | 0.83424314 |
| 53 | MP0000538_abnormal_urinary_bladder | 0.82501972 |
| 54 | MP0005410_abnormal_fertilization | 0.82384565 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 0.82186656 |
| 56 | MP0003011_delayed_dark_adaptation | 0.82160410 |
| 57 | MP0004782_abnormal_surfactant_physiolog | 0.80506147 |
| 58 | MP0009765_abnormal_xenobiotic_induced | 0.76729428 |
| 59 | MP0005395_other_phenotype | 0.70212151 |
| 60 | MP0005376_homeostasis/metabolism_phenot | 0.69483990 |
| 61 | MP0004381_abnormal_hair_follicle | 0.66602937 |
| 62 | MP0002078_abnormal_glucose_homeostasis | 0.63931269 |
| 63 | MP0002168_other_aberrant_phenotype | 0.62191103 |
| 64 | MP0001915_intracranial_hemorrhage | 0.60691939 |
| 65 | MP0003718_maternal_effect | 0.60674550 |
| 66 | MP0000230_abnormal_systemic_arterial | 0.60322014 |
| 67 | MP0002249_abnormal_larynx_morphology | 0.57684378 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 0.57342494 |
| 69 | MP0002135_abnormal_kidney_morphology | 0.56084051 |
| 70 | MP0009780_abnormal_chondrocyte_physiolo | 0.51899688 |
| 71 | MP0000371_diluted_coat_color | 0.50136396 |
| 72 | MP0002254_reproductive_system_inflammat | 0.49567142 |
| 73 | MP0010368_abnormal_lymphatic_system | 0.49408410 |
| 74 | MP0001661_extended_life_span | 0.48334421 |
| 75 | MP0003436_decreased_susceptibility_to | 0.47708587 |
| 76 | MP0008260_abnormal_autophagy | 0.47187898 |
| 77 | MP0005334_abnormal_fat_pad | 0.47030237 |
| 78 | MP0005464_abnormal_platelet_physiology | 0.46734210 |
| 79 | MP0005266_abnormal_metabolism | 0.46727691 |
| 80 | MP0003638_abnormal_response/metabolism_ | 0.46487000 |
| 81 | MP0001845_abnormal_inflammatory_respons | 0.45411075 |
| 82 | MP0003953_abnormal_hormone_level | 0.43420686 |
| 83 | MP0005377_hearing/vestibular/ear_phenot | 0.43395348 |
| 84 | MP0003878_abnormal_ear_physiology | 0.43395348 |
| 85 | MP0009379_abnormal_foot_pigmentation | 0.41838213 |
| 86 | MP0002090_abnormal_vision | 0.41441575 |
| 87 | MP0005448_abnormal_energy_balance | 0.40953008 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.40945927 |
| 89 | MP0003632_abnormal_nervous_system | 0.39437413 |
| 90 | MP0002971_abnormal_brown_adipose | 0.38338209 |
| 91 | MP0004264_abnormal_extraembryonic_tissu | 0.37997253 |
| 92 | MP0005166_decreased_susceptibility_to | 0.37566321 |
| 93 | MP0001984_abnormal_olfaction | 0.37512641 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.37423008 |
| 95 | MP0001944_abnormal_pancreas_morphology | 0.36794596 |
| 96 | MP0002132_abnormal_respiratory_system | 0.36727987 |
| 97 | MP0008872_abnormal_physiological_respon | 0.35888641 |
| 98 | MP0000604_amyloidosis | 0.33280787 |
| 99 | MP0010386_abnormal_urinary_bladder | 0.32969365 |
| 100 | MP0000467_abnormal_esophagus_morphology | 0.31606733 |
| 101 | MP0009785_altered_susceptibility_to | 0.31249406 |
| 102 | MP0003880_abnormal_central_pattern | 0.30720841 |
| 103 | MP0003690_abnormal_glial_cell | 0.30085924 |
| 104 | MP0003943_abnormal_hepatobiliary_system | 0.29451050 |
| 105 | MP0000566_synostosis | 0.29129182 |
| 106 | MP0003698_abnormal_male_reproductive | 0.28510123 |
| 107 | MP0003075_altered_response_to | 0.28408808 |
| 108 | MP0008873_increased_physiological_sensi | 0.28273010 |
| 109 | MP0003633_abnormal_nervous_system | 0.28168406 |
| 110 | MP0004142_abnormal_muscle_tone | 0.27826088 |
| 111 | MP0001119_abnormal_female_reproductive | 0.27397275 |
| 112 | MP0001542_abnormal_bone_strength | 0.27195639 |
| 113 | MP0003631_nervous_system_phenotype | 0.27184284 |
| 114 | MP0001929_abnormal_gametogenesis | 0.26848241 |
| 115 | MP0006082_CNS_inflammation | 0.26844277 |
| 116 | MP0002837_dystrophic_cardiac_calcinosis | 0.26839931 |
| 117 | MP0002098_abnormal_vibrissa_morphology | 0.25735837 |
| 118 | MP0002069_abnormal_eating/drinking_beha | 0.25654462 |
| 119 | MP0008874_decreased_physiological_sensi | 0.25565641 |
| 120 | MP0005646_abnormal_pituitary_gland | 0.25274567 |
| 121 | MP0000367_abnormal_coat/_hair | 0.24736226 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.24499011 |
| 123 | MP0009384_cardiac_valve_regurgitation | 0.24437764 |
| 124 | MP0004883_abnormal_blood_vessel | 0.24365720 |
| 125 | MP0009115_abnormal_fat_cell | 0.24355597 |
| 126 | MP0001835_abnormal_antigen_presentation | 0.24055473 |
| 127 | MP0005164_abnormal_response_to | 0.23980368 |
| 128 | MP0002909_abnormal_adrenal_gland | 0.23893909 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.23797403 |
| 130 | MP0000249_abnormal_blood_vessel | 0.23719592 |
| 131 | MP0002697_abnormal_eye_size | 0.21244296 |
| 132 | MP0000639_abnormal_adrenal_gland | 0.20945961 |
| 133 | MP0005379_endocrine/exocrine_gland_phen | 0.20331310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.04452463 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.53466385 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.29172198 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.23197981 |
| 5 | Hyperglycinuria (HP:0003108) | 4.90066571 |
| 6 | Gout (HP:0001997) | 4.86149295 |
| 7 | Glomerulonephritis (HP:0000099) | 4.85026881 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.64229906 |
| 9 | Xanthomatosis (HP:0000991) | 4.52884554 |
| 10 | Deep venous thrombosis (HP:0002625) | 4.37100302 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 4.32037282 |
| 12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.32037282 |
| 13 | Spontaneous abortion (HP:0005268) | 4.31319096 |
| 14 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.29393145 |
| 15 | Proximal tubulopathy (HP:0000114) | 4.22280803 |
| 16 | Hyperglycinemia (HP:0002154) | 4.22243946 |
| 17 | Hyperammonemia (HP:0001987) | 4.14289449 |
| 18 | Ketosis (HP:0001946) | 4.11396087 |
| 19 | Complement deficiency (HP:0004431) | 4.10510257 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.94202266 |
| 21 | Abnormality of purine metabolism (HP:0004352) | 3.93956899 |
| 22 | Abnormality of nucleobase metabolism (HP:0010932) | 3.92988643 |
| 23 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91052132 |
| 24 | Joint hemorrhage (HP:0005261) | 3.90849966 |
| 25 | Hypobetalipoproteinemia (HP:0003563) | 3.75773224 |
| 26 | Generalized aminoaciduria (HP:0002909) | 3.71636419 |
| 27 | Alkalosis (HP:0001948) | 3.59021448 |
| 28 | Nephritis (HP:0000123) | 3.54226819 |
| 29 | Hyperuricemia (HP:0002149) | 3.46719126 |
| 30 | Increased purine levels (HP:0004368) | 3.46719126 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.40961790 |
| 32 | Ketoacidosis (HP:0001993) | 3.40929972 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.40920277 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 3.40019453 |
| 35 | Fat malabsorption (HP:0002630) | 3.27425686 |
| 36 | Hyperlipoproteinemia (HP:0010980) | 3.26445382 |
| 37 | Increased circulating renin level (HP:0000848) | 3.24506408 |
| 38 | Hyperactive renin-angiotensin system (HP:0000841) | 3.22729879 |
| 39 | Epidermoid cyst (HP:0200040) | 3.20877478 |
| 40 | Hypokalemic alkalosis (HP:0001949) | 3.19557895 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.18784656 |
| 42 | Hypoglycemic coma (HP:0001325) | 3.17622203 |
| 43 | Delayed CNS myelination (HP:0002188) | 3.16212666 |
| 44 | Vascular calcification (HP:0004934) | 3.14145330 |
| 45 | Glycosuria (HP:0003076) | 3.09731032 |
| 46 | Abnormality of urine glucose concentration (HP:0011016) | 3.09731032 |
| 47 | Osteomalacia (HP:0002749) | 3.09646260 |
| 48 | Abnormality of the common coagulation pathway (HP:0010990) | 3.09344135 |
| 49 | Metabolic alkalosis (HP:0200114) | 3.05363658 |
| 50 | Mitral stenosis (HP:0001718) | 2.99158037 |
| 51 | Metabolic acidosis (HP:0001942) | 2.99036828 |
| 52 | Hypomagnesemia (HP:0002917) | 2.97246764 |
| 53 | Abnormality of complement system (HP:0005339) | 2.96125426 |
| 54 | Hypercholesterolemia (HP:0003124) | 2.93984207 |
| 55 | Reduced antithrombin III activity (HP:0001976) | 2.93819033 |
| 56 | Polyuria (HP:0000103) | 2.93615431 |
| 57 | Enlarged kidneys (HP:0000105) | 2.92474253 |
| 58 | Lethargy (HP:0001254) | 2.92263140 |
| 59 | Hyperbilirubinemia (HP:0002904) | 2.92052857 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.90957136 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.90957136 |
| 62 | Abnormal urine output (HP:0012590) | 2.89812040 |
| 63 | Abnormality of chloride homeostasis (HP:0011422) | 2.85563655 |
| 64 | Abnormality of renal excretion (HP:0011036) | 2.80904410 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.80688948 |
| 66 | Hydroxyprolinuria (HP:0003080) | 2.78427102 |
| 67 | Abnormality of proline metabolism (HP:0010907) | 2.78427102 |
| 68 | Hypolipoproteinemia (HP:0010981) | 2.77255968 |
| 69 | Hepatocellular carcinoma (HP:0001402) | 2.73181289 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.72931854 |
| 71 | Abnormality of the intrinsic pathway (HP:0010989) | 2.69793047 |
| 72 | Abnormality of vitamin metabolism (HP:0100508) | 2.67064657 |
| 73 | Rickets (HP:0002748) | 2.65667996 |
| 74 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.61603643 |
| 75 | Renal tubular acidosis (HP:0001947) | 2.60360819 |
| 76 | Cerebral edema (HP:0002181) | 2.55789926 |
| 77 | Vomiting (HP:0002013) | 2.55611867 |
| 78 | Gingival bleeding (HP:0000225) | 2.55504293 |
| 79 | Abnormality of magnesium homeostasis (HP:0004921) | 2.53225916 |
| 80 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.50196472 |
| 81 | Steatorrhea (HP:0002570) | 2.48540608 |
| 82 | Renal cortical cysts (HP:0000803) | 2.47166668 |
| 83 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.46539408 |
| 84 | Hypoalphalipoproteinemia (HP:0003233) | 2.42059673 |
| 85 | Hyperphosphaturia (HP:0003109) | 2.39663151 |
| 86 | Irritability (HP:0000737) | 2.33484652 |
| 87 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.27861368 |
| 88 | Thrombophlebitis (HP:0004418) | 2.27690777 |
| 89 | Polydipsia (HP:0001959) | 2.25747586 |
| 90 | Abnormal drinking behavior (HP:0030082) | 2.25747586 |
| 91 | Nephrolithiasis (HP:0000787) | 2.22909522 |
| 92 | Nausea (HP:0002018) | 2.22637610 |
| 93 | Fair hair (HP:0002286) | 2.22074678 |
| 94 | Pancreatitis (HP:0001733) | 2.20796252 |
| 95 | Hypoglycemic seizures (HP:0002173) | 2.20290882 |
| 96 | Neonatal onset (HP:0003623) | 2.19862052 |
| 97 | Abnormal urine phosphate concentration (HP:0012599) | 2.18738538 |
| 98 | Hemorrhage of the eye (HP:0011885) | 2.18541575 |
| 99 | Sensorimotor neuropathy (HP:0007141) | 2.18076613 |
| 100 | Malnutrition (HP:0004395) | 2.15742142 |
| 101 | Elevated alkaline phosphatase (HP:0003155) | 2.15063574 |
| 102 | Hypophosphatemia (HP:0002148) | 2.11465893 |
| 103 | Bifid scrotum (HP:0000048) | 2.10899941 |
| 104 | Arthropathy (HP:0003040) | 2.10525127 |
| 105 | Hypochromic microcytic anemia (HP:0004840) | 2.10020321 |
| 106 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08632173 |
| 107 | Tetany (HP:0001281) | 2.07712631 |
| 108 | Confusion (HP:0001289) | 2.07213542 |
| 109 | Abnormality of renin-angiotensin system (HP:0000847) | 2.06735654 |
| 110 | Hypophosphatemic rickets (HP:0004912) | 2.03903580 |
| 111 | Hyperaldosteronism (HP:0000859) | 2.02960776 |
| 112 | Menorrhagia (HP:0000132) | 2.01922014 |
| 113 | Opisthotonus (HP:0002179) | 2.00434488 |
| 114 | Myocardial infarction (HP:0001658) | 1.97157614 |
| 115 | Alveolar cell carcinoma (HP:0006519) | 1.96941507 |
| 116 | Pulmonary embolism (HP:0002204) | 1.96510614 |
| 117 | Abnormal biliary tract physiology (HP:0012439) | 1.95861439 |
| 118 | Bile duct proliferation (HP:0001408) | 1.95861439 |
| 119 | Abnormal gallbladder morphology (HP:0012437) | 1.92921177 |
| 120 | Cholelithiasis (HP:0001081) | 1.91692313 |
| 121 | Purpura (HP:0000979) | 1.90198512 |
| 122 | Abnormality of the Achilles tendon (HP:0005109) | 1.79340414 |
| 123 | Joint swelling (HP:0001386) | 1.76232225 |
| 124 | Poikilocytosis (HP:0004447) | 1.61985441 |
| 125 | Potter facies (HP:0002009) | 1.54112550 |
| 126 | Facial shape deformation (HP:0011334) | 1.54112550 |
| 127 | Cerebral palsy (HP:0100021) | 1.51738889 |
| 128 | Cholecystitis (HP:0001082) | 1.50455068 |
| 129 | Abnormal gallbladder physiology (HP:0012438) | 1.50455068 |
| 130 | Gangrene (HP:0100758) | 1.47396215 |
| 131 | Abnormality of iron homeostasis (HP:0011031) | 1.47394309 |
| 132 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.45884737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.54399804 |
| 2 | WNK4 | 5.08311245 |
| 3 | WNK3 | 5.01395696 |
| 4 | OXSR1 | 3.91269429 |
| 5 | PNCK | 3.21232514 |
| 6 | INSRR | 3.11505465 |
| 7 | STK38L | 2.98956849 |
| 8 | FGFR4 | 2.76275377 |
| 9 | IRAK3 | 2.74277390 |
| 10 | MAP3K14 | 2.29637285 |
| 11 | BRSK2 | 2.18124645 |
| 12 | ERBB4 | 2.07092320 |
| 13 | EPHA3 | 1.98947437 |
| 14 | RIPK1 | 1.95869325 |
| 15 | PINK1 | 1.95351706 |
| 16 | ERN1 | 1.92200726 |
| 17 | TNIK | 1.84350373 |
| 18 | MAPK11 | 1.83028130 |
| 19 | SGK223 | 1.78105128 |
| 20 | SGK494 | 1.78105128 |
| 21 | SGK2 | 1.75647530 |
| 22 | ZAK | 1.70335734 |
| 23 | MARK3 | 1.64500345 |
| 24 | TAOK3 | 1.63200379 |
| 25 | CSNK1G1 | 1.49492990 |
| 26 | PRKCG | 1.46116895 |
| 27 | MST1R | 1.42525304 |
| 28 | TYK2 | 1.35704586 |
| 29 | MAP3K4 | 1.34055234 |
| 30 | STK39 | 1.33906186 |
| 31 | SGK3 | 1.27068668 |
| 32 | NTRK3 | 1.22843979 |
| 33 | PIK3CA | 1.22639205 |
| 34 | EPHA4 | 1.22391678 |
| 35 | EIF2AK3 | 1.21731500 |
| 36 | MUSK | 1.20830079 |
| 37 | NEK2 | 1.18238558 |
| 38 | CAMKK2 | 1.16525617 |
| 39 | SIK1 | 1.15238939 |
| 40 | MAP2K4 | 1.11785787 |
| 41 | ACVR1B | 1.03981166 |
| 42 | CSNK1G3 | 1.03764596 |
| 43 | RPS6KA5 | 1.03121058 |
| 44 | IRAK4 | 1.02155644 |
| 45 | TGFBR2 | 1.01812324 |
| 46 | FRK | 1.01725851 |
| 47 | CASK | 1.01308451 |
| 48 | NEK9 | 1.00343724 |
| 49 | MAP2K3 | 0.99185845 |
| 50 | FER | 0.98330103 |
| 51 | PIK3CG | 0.98137420 |
| 52 | MAP3K3 | 0.96629982 |
| 53 | TLK1 | 0.94357092 |
| 54 | STK16 | 0.92911398 |
| 55 | PDK2 | 0.89816488 |
| 56 | MAP4K2 | 0.89493903 |
| 57 | IKBKE | 0.89424953 |
| 58 | ABL2 | 0.89278482 |
| 59 | EIF2AK1 | 0.89181768 |
| 60 | TXK | 0.85727296 |
| 61 | AKT3 | 0.83901627 |
| 62 | PRKAA2 | 0.83658862 |
| 63 | CDK9 | 0.83122240 |
| 64 | OBSCN | 0.83097184 |
| 65 | CSNK1A1L | 0.82672151 |
| 66 | PRKG1 | 0.82220532 |
| 67 | CSNK1G2 | 0.81502173 |
| 68 | MAP2K6 | 0.80539394 |
| 69 | EIF2AK2 | 0.80300489 |
| 70 | PKN2 | 0.78611094 |
| 71 | DYRK2 | 0.78534423 |
| 72 | PDK3 | 0.78216219 |
| 73 | PDK4 | 0.78216219 |
| 74 | GRK6 | 0.77840185 |
| 75 | NLK | 0.77682491 |
| 76 | IRAK1 | 0.76805356 |
| 77 | TIE1 | 0.76749699 |
| 78 | TAOK2 | 0.76599795 |
| 79 | JAK1 | 0.76426013 |
| 80 | GRK1 | 0.74872553 |
| 81 | IGF1R | 0.73736036 |
| 82 | IRAK2 | 0.73246487 |
| 83 | CSNK1A1 | 0.71938764 |
| 84 | MAPKAPK3 | 0.70767907 |
| 85 | MAPK7 | 0.69680007 |
| 86 | JAK2 | 0.69323942 |
| 87 | ADRBK2 | 0.68811975 |
| 88 | IKBKB | 0.66326326 |
| 89 | MAP3K7 | 0.65361448 |
| 90 | MAP2K7 | 0.64943493 |
| 91 | PRKCE | 0.64851979 |
| 92 | PRKACA | 0.64485660 |
| 93 | CSNK1D | 0.63769614 |
| 94 | CDK8 | 0.63350756 |
| 95 | CHUK | 0.60558642 |
| 96 | GSK3A | 0.60088984 |
| 97 | PIM1 | 0.59634044 |
| 98 | PRKAA1 | 0.57134782 |
| 99 | RET | 0.56563949 |
| 100 | VRK1 | 0.56451356 |
| 101 | MAPK12 | 0.55861270 |
| 102 | CSNK1E | 0.55240408 |
| 103 | GRK7 | 0.55226022 |
| 104 | STK38 | 0.55112749 |
| 105 | WEE1 | 0.54892996 |
| 106 | TBK1 | 0.54784186 |
| 107 | MAP3K6 | 0.54648452 |
| 108 | FLT3 | 0.54121114 |
| 109 | RPS6KB1 | 0.50751225 |
| 110 | MAPK15 | 0.50579402 |
| 111 | ERBB2 | 0.50043608 |
| 112 | MAPK4 | 0.49961676 |
| 113 | FGFR3 | 0.49604542 |
| 114 | FGFR2 | 0.48612866 |
| 115 | PBK | 0.47946242 |
| 116 | BCR | 0.47319262 |
| 117 | STK24 | 0.46783024 |
| 118 | PRKCZ | 0.46410023 |
| 119 | PRKACG | 0.45838016 |
| 120 | WNK1 | 0.45831294 |
| 121 | BMPR2 | 0.45628707 |
| 122 | TNK2 | 0.45595106 |
| 123 | MET | 0.44805678 |
| 124 | SIK3 | 0.44609373 |
| 125 | SGK1 | 0.44524876 |
| 126 | PRKCQ | 0.44257643 |
| 127 | DAPK2 | 0.43995896 |
| 128 | NEK1 | 0.43763744 |
| 129 | BRSK1 | 0.42990855 |
| 130 | NUAK1 | 0.42568429 |
| 131 | PLK4 | 0.42070857 |
| 132 | KDR | 0.39027792 |
| 133 | MAP3K5 | 0.38678951 |
| 134 | MYLK | 0.38551227 |
| 135 | CSNK2A1 | 0.37025207 |
| 136 | PRKCB | 0.36905269 |
| 137 | PRKCD | 0.36825182 |
| 138 | PRKCA | 0.36591908 |
| 139 | NME2 | 0.36057616 |
| 140 | RPS6KA3 | 0.36016702 |
| 141 | YES1 | 0.35998253 |
| 142 | PKN1 | 0.35693854 |
| 143 | PDPK1 | 0.35436511 |
| 144 | PRPF4B | 0.34039591 |
| 145 | CAMK2G | 0.33993653 |
| 146 | DYRK1B | 0.33394262 |
| 147 | LATS1 | 0.33347695 |
| 148 | BMPR1B | 0.32963972 |
| 149 | PRKACB | 0.32063242 |
| 150 | CDK3 | 0.31812878 |
| 151 | PIM2 | 0.30115830 |
| 152 | STK4 | 0.28748735 |
| 153 | LYN | 0.27898555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.80794802 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.54906373 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32605541 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.83026440 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.80192876 |
| 6 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65787582 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.64778126 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.63874252 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.59231607 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.56528267 |
| 11 | Peroxisome_Homo sapiens_hsa04146 | 2.45207497 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39144247 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.32566782 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.29494102 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.22787197 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.14482928 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09085003 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98578726 |
| 19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.95307879 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92335646 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.84004534 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81284386 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75408962 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.74577699 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.73858833 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.73614381 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73070576 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.68911212 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.66915793 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64085228 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.63588272 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.61811841 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.57011315 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56398607 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.54299139 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.51731645 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46008431 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.45427354 |
| 39 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.41071644 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36506534 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35090953 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34593347 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.32717783 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28379100 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28009390 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.27423211 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25872392 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23591152 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20909845 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.19699741 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15108875 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.11680070 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11559033 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.09467544 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.01092049 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97203119 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.96169815 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94789525 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93907554 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.87185526 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70676481 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65950416 |
| 63 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.61383310 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60830024 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57068514 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53586835 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44857323 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31628696 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30138783 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.28475012 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21812822 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20691694 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.19043287 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18436415 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.12825071 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.11942756 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.09421120 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.07689126 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07443504 |
| 80 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.07231453 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.04236989 |
| 82 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.03760582 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.03548031 |
| 84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.03533133 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.01914857 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.01858150 |
| 87 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.01773704 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.00250293 |
| 89 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.2052696 |
| 90 | Cocaine addiction_Homo sapiens_hsa05030 | -0.2005968 |
| 91 | GABAergic synapse_Homo sapiens_hsa04727 | -0.2000022 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | -0.1919160 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1734418 |
| 94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1581886 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1566491 |
| 96 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1549846 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1465030 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1451526 |
| 99 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1338099 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1291480 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1203972 |
| 102 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1077338 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1060835 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0928262 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0899897 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0857643 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | -0.0830192 |
| 108 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0505926 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0456017 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0428397 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0422194 |
| 112 | Lysosome_Homo sapiens_hsa04142 | -0.0369256 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0253718 |

